Results of the summarizing process for the arXiv paper: 2502.13344v3

In the realm of drug discovery, biomedical knowledge graphs (KGs) play a crucial role in encoding rich and structured information. However, extracting meaningful insights from these large-scale KGs poses a significant challenge due to their complex structure. Existing methods for retrieving biomedical subgraphs are typically tailored for graph neural networks (GNNs), which limits their compatibility with other paradigms such as large language models (LLMs). To address this limitation, a novel model-agnostic retrieval framework called K-Paths has been introduced. <br> K-Paths is designed to extract structured, diverse, and biologically meaningful multi-hop paths from dense biomedical KGs. These paths enable the prediction of unobserved interactions between drugs, as well as between drugs and diseases. Importantly, K-Paths supports inductive reasoning by including entities that were not seen during training. This training-free framework utilizes a diversity-aware adaptation of Yen's algorithm to extract the K shortest loopless paths between entities in a query. It prioritizes biologically relevant and relationally diverse connections, thereby generating concise and interpretable reasoning chains.<br> The extracted paths from K-Paths can be seamlessly integrated with both LLMs and GNNs to enhance generalization, accuracy, and explainable inference capabilities. Experimental results on benchmark datasets demonstrate the effectiveness of K-Paths in improving zero-shot reasoning across state-of-the-art LLMs.<br> For instance,Tx-Gemma 27B shows improvements of 19.8 and 4.0 F1 points on tasks related to predicting interaction severity and drug repurposing respectively, while Llama 70B achieves gains of 8.5 and 6.2 points on the same tasks.<br> Moreover,K-Paths enhances the training efficiency of EmerGNN—a leading GNN—by significantly reducing the size of the KG while maintaining predictive performance levels. Beyond efficiency gains, K-Paths serves as a bridge between KGs and LLMs, enabling scalable and explainable scientific discovery augmented by LLMs.<br> To facilitate further research in inductive reasoning within the domain of drug discovery, the authors have made their code available along with retrieved paths as a benchmark resource for the community. This innovative approach holds promise for advancing drug discovery efforts through enhanced reasoning capabilities facilitated by structured path extraction from biomedical KGs.

• - Biomedical knowledge graphs (KGs) are crucial for encoding rich and structured information in drug discovery.
• - Extracting meaningful insights from large-scale KGs is challenging due to their complex structure.
• - K-Paths is a novel model-agnostic retrieval framework designed to extract structured, diverse, and biologically meaningful multi-hop paths from dense biomedical KGs.
• - K-Paths enables the prediction of unobserved interactions between drugs and diseases, supporting inductive reasoning by including unseen entities during training.
• - The framework utilizes a diversity-aware adaptation of Yen's algorithm to extract the K shortest loopless paths between entities in a query, prioritizing biologically relevant and relationally diverse connections.
• - Extracted paths from K-Paths can be integrated with both large language models (LLMs) and graph neural networks (GNNs) to enhance generalization, accuracy, and explainable inference capabilities.
• - Experimental results show that K-Paths improves zero-shot reasoning across state-of-the-art LLMs, with significant improvements on tasks related to predicting interaction severity and drug repurposing.
• - K-Paths enhances the training efficiency of EmerGNN—a leading GNN—by reducing the size of the KG while maintaining predictive performance levels.
• - The framework serves as a bridge between KGs and LLMs, enabling scalable and explainable scientific discovery augmented by LLMs.
• - Authors have made their code available along with retrieved paths as a benchmark resource for further research in inductive reasoning within drug discovery.

Summary- Biomedical knowledge graphs (KGs) are like maps that hold important information about medicines. - It can be hard to understand this information because it is very complex and detailed. - K-Paths is a new way to find useful paths in these graphs, helping us predict how drugs and diseases interact. - By using K-Paths, we can make better guesses about interactions between drugs and diseases even if we haven't seen them before. - This method helps scientists study connections between different things in a smart and diverse way. Definitions- Biomedical knowledge graphs (KGs): Maps full of important details about medicines and health. - Structured: Organized in a clear and logical way. - Framework: A set of rules or methods for doing something specific. - Entities: Different things or objects within the graph that are connected in some way. - Inductive reasoning: Making educated guesses based on patterns or existing information.

Introduction

Drug discovery is a complex and time-consuming process that involves identifying potential new drugs for treating diseases. In recent years, biomedical knowledge graphs (KGs) have emerged as an essential tool in this field. These KGs encode rich and structured information about drugs, diseases, genes, proteins, and their relationships. However, extracting meaningful insights from these large-scale KGs poses a significant challenge due to their complex structure. Existing methods for retrieving subgraphs from biomedical KGs are typically tailored for graph neural networks (GNNs), which limits their compatibility with other paradigms such as large language models (LLMs). This limitation hinders the integration of diverse sources of information and restricts the generalization capabilities of these models. To address this issue, a team of researchers has introduced a novel model-agnostic retrieval framework called K-Paths. This framework is designed to extract structured, diverse, and biologically meaningful multi-hop paths from dense biomedical KGs. These paths enable the prediction of unobserved interactions between drugs and between drugs and diseases. Importantly, K-Paths supports inductive reasoning by including entities that were not seen during training.

The K-Paths Framework

K-Paths utilizes a diversity-aware adaptation of Yen's algorithm to extract the K shortest loopless paths between entities in a query. This algorithm prioritizes biologically relevant and relationally diverse connections while generating concise and interpretable reasoning chains. The extracted paths from K-Paths can be seamlessly integrated with both LLMs and GNNs to enhance generalization, accuracy, and explainable inference capabilities. This integration allows for more comprehensive analysis of drug-disease interactions by incorporating both textual data from LLMs and structural data from GNNs.

Improving Zero-Shot Reasoning

Experimental results on benchmark datasets demonstrate the effectiveness of K-Paths in improving zero-shot reasoning across state-of-the-art LLMs. For instance, Tx-Gemma 27B shows improvements of 19.8 and 4.0 F1 points on tasks related to predicting interaction severity and drug repurposing respectively, while Llama 70B achieves gains of 8.5 and 6.2 points on the same tasks. This improvement is attributed to K-Paths' ability to extract diverse paths that capture different aspects of drug-disease interactions, leading to more accurate predictions.

Enhancing Training Efficiency

K-Paths also enhances the training efficiency of EmerGNN – a leading GNN – by significantly reducing the size of the KG while maintaining predictive performance levels. This reduction in size is achieved by extracting only the most relevant paths from the KG, thereby reducing noise and redundancy in the data. Moreover, K-Paths serves as a bridge between KGs and LLMs, enabling scalable and explainable scientific discovery augmented by LLMs. This integration allows for more efficient use of both textual data from LLMs and structural data from KGs.

Benchmark Resource for Further Research

To facilitate further research in inductive reasoning within the domain of drug discovery, the authors have made their code available along with retrieved paths as a benchmark resource for the community. This resource will enable researchers to compare their methods against K-Paths' results on various datasets and further improve upon this innovative approach.

Conclusion

In conclusion, K-Paths is a novel model-agnostic retrieval framework that enables structured path extraction from biomedical KGs. It addresses limitations posed by existing methods tailored for specific paradigms such as GNNs or LLMs and allows for seamless integration with both models to enhance generalization capabilities. Experimental results demonstrate its effectiveness in improving zero-shot reasoning across state-of-the-art LLMs and enhancing training efficiency of GNNs. Furthermore, K-Paths serves as a bridge between KGs and LLMs, enabling scalable and explainable scientific discovery in the field of drug discovery. The availability of K-Paths' code and retrieved paths as a benchmark resource for further research holds promise for advancing drug discovery efforts through enhanced reasoning capabilities facilitated by structured path extraction from biomedical KGs.